• Publications
  • Influence
Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
UNLABELLED Small-cell lung cancer has a high chemotherapeutic sensitivity but with disappointing outcome results. Patients with “sensitive disease” are those who respond to treatment with a longExpand
  • 30
  • 1
Noninferiority Trials in Second-Line Treatments of Nonsmall Cell Lung Cancer: A Systematic Review of Literature With Meta-analysis of Phase III Randomized Clinical Trials
Background:To assess the role of the novel second-line treatments in nonsmall cell lung cancer (NSCLC). Methods:A systematic review of the literature with meta-analysis of phase III randomizedExpand
  • 6
  • 1
Second line treatments in advanced platinum-resistant non small cell lung cancer. A critical review of literature.
In the last 10 years the medical approach to platinum-resistant Non Small Cell Lung Cancer (NSCLC) has radically changed, passing from a lack of evidence of any primary treatment against the tumor,Expand
  • 11
Bevacizumab in the Treatment of Advanced, Non-Squamous Non-Small Cell Lung Cancer: An Evidence-Based Approach
Background: To assess the efficacy and safety of bevacizumab-containing regimens in the treatment of advanced, chemotherapy-naive, non-squamous non-small cell lung cancer (NSCLC) on the basis of theExpand
  • 8
Adjuvant treatments in pancreatic cancer: Preliminary data of a pooled analysis.
4042 Background: To assess the role of adjuvant treatments (AT; chemotherapy [AC] and/or chemo-radiotherapy [ACR]) in radically resected pancreatic cancer. METHODS A systematic review of literatureExpand
  • 1
Final outcome results of platinum-sensitive small cell lung cancer (SCLC) patients treated with platinum-based chemotherapy rechallenge: A multi-institutional retrospective analysis.
7600 Background: Rechallenge might be used as rescue therapy in progressing platinum-sensitiveSmall Cell Lung Cancer (SCLC). This international multicenter retrospective analysis evaluates theExpand
  • 2
Adjuvant therapy in resected pancreatic cancer: A systematic review of literature with meta-analysis of randomized clinical trials.
342 Background: To assess the role of adjuvant treatments (AT), adjuvant chemotherapy (AC) and adjuvant chemo-radiotherapy (ACR) in resected pancreatic adenocarcinoma. METHODS A systematic reviewExpand
The palliative effect of EGFR inhibitors in platinum-resistant NSCLC.
e19053 Background: To assess the clinical benefit of EGFR-inhibitors (erlotinib or gefitinib) in terms of quality of life and symptoms control in platinum-resistant NSCLC. METHODS A systematicExpand
Contents Vol. 80, 2011
[Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
BACKGROUND Aim of our work was to assess the role of prognostic and predictive factors in patients to be treated with II and III line chemotherapy in metastatic colorectal cancer. METHODS All theExpand